A recent study indicates that people who discontinue popular weight-loss injections like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who halt conventional lifestyle plans.
Research printed in a leading health publication points out that while obese individuals can lose a large proportion of their body weight while on the medication, the weight is regained at an average rate of nearly a kilo each month once they quit.
"People buying such medications need to be aware of the potential of quick rebound weight gain when the treatment ends," stated researcher Dr. Susan Jebb.
Such speed of recovery means a return to starting mass in about 18 months.
Analyzing Approaches
The analysis, which reviewed 37 of trials involving over 9,000 of participants, compared the effects of GLP-1 agonists with older methods.
Researchers note that individuals who lose weight through lifestyle changes alone typically see a less rapid weight regain—approximately 0.1 kg a month—once they finish.
Understanding the Fast Rebound
Experts propose the way of the jabs is key to understanding the heightened regain.
These medications mimic a body's own chemical called GLP-1, which controls appetite.
"Sustained high doses of the hormone levels several times higher than the body's typical production might result in the body to produce less of its own natural hormone, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' results in hunger is no longer kept in check, making overeating much more probable."
A Chronic Disease?
Medical guidelines suggest the injections for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians contend that, due to the high risk of relapse, the therapy should be considered life-long.
This view is supported by pharmaceutical companies, who state that the findings "underscore the persistent nature of excess weight," similar to managing diseases like hypertension.
Patient Accounts
Users who have stopped the jabs explain a intense return of hunger.
"I experienced a trigger activating and you become ravenous," recalled one woman.
This difficulty is worsened if individuals have not established lasting lifestyle or habit changes during therapy.
Widespread Adoption
Recent estimates show that millions of people in the UK have tried weight-loss jabs in the last 12 months, with desire being substantial.
- Adoption is greater among females than males.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, clinicians stress that while these medications are effective agents for weight loss, they are not a magic solution and lasting health benefits hinges on ongoing lifestyle changes.
